| NCT01100502 |
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100450 |
Progressive Resistance Training in Patients With Class III Obesity |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100359 |
Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100333 |
GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100320 |
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100294 |
Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100268 |
Enhancing Attention in Adults With Compulsive Hoarding |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100203 |
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100151 |
ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100060 |
A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01100034 |
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099995 |
Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099969 |
Endotrol-tracheal Tube Assisted Endotracheal Intubation During Video Laryngoscopy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099956 |
Low Grade Inflammation in Type 1 Diabetes Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099904 |
A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099761 |
Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099735 |
Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099657 |
Virtual Reality Hypnosis for Chronic Pain Reduction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099618 |
Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099605 |
Continuous Infusion of Local Anesthetic for Optimal Post Operative Pain Control Following Hemorrhoidectomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099592 |
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099566 |
The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099358 |
Study in Advanced Solid Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099332 |
Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099293 |
Cerebrovascular Reactivity in Hepatic Encephalopathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099267 |
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099202 |
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099150 |
Dark Chocolate and Platelet Function in Humans |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099059 |
Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099033 |
The Biologic Basis of Hernia Formation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01099020 |
Temporal Pattern of Circulating DNA for Patients Receiving Irradiation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098994 |
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098968 |
Education and Fitness: EDUFIT Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098903 |
Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098851 |
Oxygen Saturation Monitoring During Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098760 |
Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098734 |
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098695 |
Early Family-Centered Prevention of Drug Use Risk (Aka Early Steps) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098669 |
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098656 |
Lenalidomide Maintenance Post-debulking in Advanced CTCL |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098604 |
The Comparison of 32mm and 28mm Head Components in Alumina-alumina Total Hip Arthroplasty |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098461 |
Dose Ranging Study of Albiglutide in Japanese Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098435 |
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098357 |
Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098318 |
Rhodiola Rosea Therapy of Major Depressive Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098305 |
Efficacy of Varenicline for Smokeless Tobacco Use in India |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098292 |
Observational Study of Control Participants for the MAPP Research Network |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098266 |
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098058 |
Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098032 |
RenalGuard System and Contrast Media |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01098006 |
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097993 |
A Single-centre, Randomised, Double-blind, Controlled, Parallel-group Study to Evaluate the Effect of a Fermented Dairy Product on Abdominal Distension, Digestive Symptoms and Rectal Sensitivity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097967 |
Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097902 |
Study of Experimental Models of Pain and Inflammation. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097850 |
Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097759 |
LigaSure Hemorrhoidectomy Versus Stapled Hemorrhoidopexy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097733 |
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097720 |
Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097694 |
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097668 |
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097603 |
Larsen & Toubro (L&T) Noninvasive Blood Pressure Module Performance Validation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097551 |
Endothelial Dysfunction and Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097460 |
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097434 |
Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097395 |
Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097369 |
Elitek (Rasburicase) Immuno-Monitoring Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097356 |
The Effect of Probiotics on the Clearance of the Human Papillomavirus and on Cytological Lesions Caused by the Virus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097304 |
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097161 |
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097135 |
Evaluating the Effectiveness of 2 Surgical Skin Preparation Methods in Reducing Surgical Wound Drainage After Total Hip or Knee Replacement |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097057 |
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097018 |
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01097005 |
Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096992 |
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096966 |
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096927 |
Non Operative Treatment for Acute Appendicitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096758 |
Follow-up of Adult Phenylketonuria (PKU) Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096732 |
Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096706 |
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096693 |
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096667 |
Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096602 |
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096550 |
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096459 |
Nerve Rerouting Treatment for Neurogenic Bladder in Spina Bifida |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096433 |
Circadian Variations of Prostaglandin in Sleep Apnea |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096420 |
Acupuncture in Chronic Migraine: A Randomized Controlled Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096394 |
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096368 |
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096303 |
Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096251 |
STRATOB: a Randomized Controlled Clinical Trial of Cognitive Behavioural Therapy and Brief Strategic Therapy With Telecare for Binge-eating Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096212 |
Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096160 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096134 |
Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096095 |
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096069 |
Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096056 |
Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01096004 |
Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095861 |
Comparison of Parker Flex-Tip Endotracheal Tube to Standard Endotracheal Tube |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095835 |
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095757 |
Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095718 |
Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095705 |
Hypnosis for Transesophageal Echocardiography |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095692 |
Evaluating the Necessity of TOT Implantation in Women With Pelvic Organ Prolapse and Occult Stress Urinary Incontinence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095666 |
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095458 |
Phone Versus Clinical Approach to Weight Loss |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095432 |
Partial Wave Spectroscopic Detection of Colon Cancer Risk |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095393 |
National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095367 |
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095302 |
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095250 |
Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095159 |
TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095133 |
Do Acid Sensing Ion Channels Contribute to Heartburn? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095120 |
Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095094 |
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095068 |
Effects of Physical Exercise in Type 2 Diabetics |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01095003 |
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094951 |
Engaging Depressed Low-Income Seniors in Mental Health Services |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094860 |
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094834 |
A Multiple Dose Study of DWP05195 in Healthy Adult Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094808 |
Pregabalin and Colonic Function |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094795 |
Safety Study of Abatacept in Sweden |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094769 |
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094756 |
Brain, Obesity, Dopamine and You Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094704 |
Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094561 |
Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094535 |
Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094457 |
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094418 |
Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes Mellitus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094405 |
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094392 |
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094366 |
Paracervical Block for Pain Control in First Trimester Abortion |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094327 |
Proteinuria in Pre and Post Transplant |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094158 |
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094132 |
Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094106 |
Infiltration Analgesia After Caesarean Section |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094093 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094067 |
Tezosentan in Patients With Pulmonary Arterial Hypertension |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01094002 |
Effects of a Structured Occupational Therapy Intervention in an Acute Geriatric Unit |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093950 |
White Light Scanning to Aid Body Contouring: A Pilot Project |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093859 |
An Exploratory Phase 1 Microdose Study of PRX-105 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093833 |
A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093820 |
Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093794 |
Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093768 |
Brain Imaging Study of Adults With Autism Spectrum Disorders |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093703 |
Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093651 |
Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093560 |
Fat Effects in Women With Metabolic Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093534 |
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093495 |
Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093469 |
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093456 |
Diurnal Variation of Uremic Solutes in Peritoneal Dialysis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093404 |
Thrombus Aspiration in Myocardial Infarction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093261 |
Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093235 |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093157 |
A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093118 |
A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093105 |
An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093092 |
Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093066 |
Prospective Multicentric Evaluation of a Bladder Preservation Strategy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01093027 |
Electrophysiological Study of the Effects of Limb Cooling on Essential Tremor |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092858 |
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092832 |
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092806 |
Insulin Secretion and Advagraf |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092793 |
Effect of Superba Krill on Inflammation in Patients With Coronary Artery Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092767 |
Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092728 |
Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092702 |
Varenicline For Smokers In Recovery From Alcohol Dependence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092650 |
Determining Levels of [D10] Phenanthrene Tetraol in Smokers' Urine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092559 |
Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092533 |
Myfortic for the Treatment of Non-infectious Intermediate Uveitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092520 |
Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092494 |
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092468 |
Comparison of Harmonic Scalpel to Conventional Diathermy in Perforator Flap Elevation for Head and Neck Reconstruction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092403 |
Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092351 |
Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092260 |
Renal Function Measurements in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092234 |
Effectiveness of an Observational Unit at St. Olavs Hospital |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092195 |
Gardasil Vaccination in Post Stem Cell Transplant Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092169 |
Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092156 |
Prenatal Breastfeeding Education to Reduce Nipple Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01092104 |
A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091961 |
Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091935 |
Safety of Intravenous Lidocaine Infusions |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091857 |
Mediators and Moderators of Exercise Behavior Change |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091818 |
Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091805 |
Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091792 |
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091766 |
Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091558 |
Study of Effects of L-Arginine in Colitis and Colon Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091532 |
A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091493 |
Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091467 |
Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091402 |
Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091350 |
Influence of Equilibration Rate Constant (ke0) of Propofol on the Effect Site Concentration for Loss of Consciousness |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091259 |
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091233 |
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091220 |
Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091194 |
Effect of Exercise After Heart Transplantation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091168 |
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01091103 |
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|